130 related articles for article (PubMed ID: 17614770)
1. COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy.
Vondrichova T; de Capretz A; Parikh H; Frenander C; Asman P; Aberg M; Groop L; Hallengren B; Lantz M
Thyroid; 2007 Jun; 17(6):511-7. PubMed ID: 17614770
[TBL] [Abstract][Full Text] [Related]
2. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of immediate early genes in active Graves' ophthalmopathy.
Lantz M; Vondrichova T; Parikh H; Frenander C; Ridderstråle M; Asman P; Aberg M; Groop L; Hallengren B
J Clin Endocrinol Metab; 2005 Aug; 90(8):4784-91. PubMed ID: 15928252
[TBL] [Abstract][Full Text] [Related]
4. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
[TBL] [Abstract][Full Text] [Related]
5. [Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy].
Yi WS; Xu XL
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):156-61. PubMed ID: 21426847
[TBL] [Abstract][Full Text] [Related]
6. Gene expression in Graves' ophthalmopathy and arm lymphedema: similarities and differences.
Planck T; Parikh H; Brorson H; Mårtensson T; Åsman P; Groop L; Hallengren B; Lantz M
Thyroid; 2011 Jun; 21(6):663-74. PubMed ID: 21510802
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of thyrotropin receptor activation on human orbital preadipocytes.
Zhang L; Baker G; Janus D; Paddon CA; Fuhrer D; Ludgate M
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5197-203. PubMed ID: 17122103
[TBL] [Abstract][Full Text] [Related]
8. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
Zhang C; Zhang X; Ma L; Peng F; Huang J; Han H
Endocrine; 2012 Apr; 41(2):248-55. PubMed ID: 22237514
[TBL] [Abstract][Full Text] [Related]
10. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M
J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Orbital Preadipocyte Adipogenesis Between Pediatric and Adult Graves Ophthalmopathy.
Choi HY; Jung JH; Ahn JH
J Craniofac Surg; 2020; 31(3):727-730. PubMed ID: 31634317
[TBL] [Abstract][Full Text] [Related]
14. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS
J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093
[TBL] [Abstract][Full Text] [Related]
15. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
16. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
[TBL] [Abstract][Full Text] [Related]
17. [Mevastatin inhibits the differentiation of thyroid-associated ophthalmopathy derived orbital preadipocytes].
Yi W; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):511-7. PubMed ID: 20543477
[TBL] [Abstract][Full Text] [Related]
18. Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
Zhang L; Grennan-Jones F; Draman MS; Lane C; Morris D; Dayan CM; Tee AR; Ludgate M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1183-90. PubMed ID: 24758182
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
20. Culture and differentiation of human orbital preadipocytes in thyroid-associated ophthalmopathy.
Wang L; Wu Z; Yan J; Yang H; Chen Z
Yan Ke Xue Bao; 2005 Mar; 21(1):27-30, 37. PubMed ID: 17162913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
